Albumin-coated tympanostomy tubes: Prospective, double-blind clinical study

Laryngoscope

Volumn 114, Issue 11 I, 2004, Pages 2038-2043

  Kinnari, Teemu J ^a   Rihkanen, Heikki ^b   Laine, Timo ^c   Salonen, Eeva Marjatta ^a   Jero, Jussi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b JORVI HOSPITAL   (Finland)

^c Leppavaara Social and Health Center   (Finland)

Author keywords

Albumin coating; Otorrhea; Sequelae; Tube occlusion; Tympanostomy tube

Indexed keywords

ALBUMIN; FIBRONECTIN; GLYCOPROTEIN; HUMAN SERUM ALBUMIN; TITANIUM;

ADOLESCENT; ALBUMIN COATED TYMPANOSTOMY TUBE; ARTICLE; BACTERIUM; BLEEDING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FINLAND; FOLLOW UP; HUMAN; IMPLANT; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCCLUSION; OTORRHEA; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; THROMBOCYTE; TREATMENT OUTCOME; TUBE OCCLUSION; TYMPANOSTOMY TUBE;

ADOLESCENT; ALBUMINS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; EQUIPMENT DESIGN; FEMALE; HUMANS; INFANT; MALE; MIDDLE EAR VENTILATION; PROSPECTIVE STUDIES;

EID: 9144228179     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000147944.20676.17     Document Type: Article

References (15)

1. Armstrong BW. A new treatment for chronic secretory otitis media. AMA Arch Otolaryngol 1954;59:653-654.
2. Isaacson G, Rosenfeld RM. Care of the child with tympanostomy tubes. Pediatr Clin North Am 1996;43:1183-1193.
3. Kay DJ, Nelson M, Rosenfeld RM. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg 2001;124:374-380.
4. Reid AP, Proops DW, Smallman LA. Why do tympanostomy tubes block? Clin Otolaryngol 1988;13:279-283.
5. Weigel MT, Parker MY, Goldsmith MM, et al. A prospective randomized study of four commonly used tympanostomy tubes. Laryngoscope 1989;99:252-256.
6. Handler SD, Miller L, Potsic WP, et al. A prospective study of titanium ventilation tubes. Int J Pediatr Otorhinolaryngol 1988;16:55-60.
7. Kinnari TJ, Salonen EM, Jero J. New method for coating tympanostomy tubes to prevent tube occlusions. Int J Pediatr Otorhinolaryngol 2001;58:107-111.
8. Chang TM. Platelet-surface interaction: effect of albumin coating or heparin complexing on thrombogenic surfaces. Can J Physiol Pharmacol 1974;52:275-285.
9. Kinnari TJ, Peltonen LI, Kuusela P, et al. Bacterial adherence to titanium surface coated with human serum albumin. Otol Neurotol In press.
10. An YH, Bradley J, Powers DL, Friedman RJ. The prevention of prosthetic infection using a cross-linked albumin coating in a rabbit model. J Bone Joint Surg Br 1997;79:816-819.
11. Kinnari TJ, Salonen EM, Jero J. Durability of the binding inhibition of albumin coating on tympanostomy tubes. Int J Pediatr Otorhinolaryngol 2003;67:157-164.
12. Shanks JE, Stelmachowicz PG, Beauchaine KL, Schulte L. Equivalent ear canal volumes in children pre- and post-tympanostomy tube insertion. J Speech Hear Res 1992;35:936-941.
13. al-Khaffaf H, Charlesworth D. Albumin-coated vascular prostheses: a five-year follow-up. J Vasc Surg 1996;23:686-690.
14. Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin: serious adverse events reported worldwide in 1998-2000. Br J Anaesth 2003;91:625-630.
15. Reynolds EC, Wong A. Effect of adsorbed protein on hydroxyapatite zeta potential and Streptococcus mutans adherence. Infect Immun 1983;39:1285-1290.